Table 11.8

Adjusted Graft Survival, Heart Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

  3 Months 1 Year 3 Years 5 Years
(Tx 2004 - 2005) (Tx 2004 - 2005) (Tx 2002 - 2005) (Tx 2000 - 2005)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 4,017 91.7% 0.4% 4,017 87.3% 0.5% 8,149 79.4% 0.5% 12,479 73.2% 0.5%
Primary Diagnosis Coronary Artery Disease 1,550 91.4% 0.8% 1,550 87.5% 0.9% 3,301 78.8% 0.9% 5,187 72.1% 0.8%
Cardiomyopathy 1,959 94.4% 0.5% 1,959 90.2% 0.7% 3,861 81.7% 0.7% 5,843 76.2% 0.7%
Congenital Heart Disease 383 78.4% 2.8% 383 70.4% 3.3% 738 69.5% 2.3% 1,066 61.9% 2.2%
Valvular Heart Disease 84 89.4% 3.2% 84 86.2% 3.6% 177 80.5% 3.2% 287 73.0% 3.0%
Other 26 88.2% 6.3% 26 84.2% 7.1% 44 79.5% 6.0% 55 61.4% 11.0%
Unknown 15 93.5% 6.0% 15 93.5% 6.0% 28 60.6% 12.1% 41 47.8% 11.0%


Source: OPTN/SRTR Data as of May 1, 2007.

(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Graft survival follows individual transplants until graft failure. Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on heart and heart-lung transplants.

Multi-organ transplants are excluded.

Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.